ATE15071T1 - Verfahren zur herstellung eines aus blutbahnen gewonnenen aktiven fibrinolytischen prinzips sowie das so hergestellte enzym. - Google Patents

Verfahren zur herstellung eines aus blutbahnen gewonnenen aktiven fibrinolytischen prinzips sowie das so hergestellte enzym.

Info

Publication number
ATE15071T1
ATE15071T1 AT82830100T AT82830100T ATE15071T1 AT E15071 T1 ATE15071 T1 AT E15071T1 AT 82830100 T AT82830100 T AT 82830100T AT 82830100 T AT82830100 T AT 82830100T AT E15071 T1 ATE15071 T1 AT E15071T1
Authority
AT
Austria
Prior art keywords
enzyme
blood
principle
prepared
preparation
Prior art date
Application number
AT82830100T
Other languages
English (en)
Inventor
Gaetano Comi
Maurizio Pandolfi
Original Assignee
Manetti & Roberts Italo Brit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Manetti & Roberts Italo Brit filed Critical Manetti & Roberts Italo Brit
Application granted granted Critical
Publication of ATE15071T1 publication Critical patent/ATE15071T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AT82830100T 1981-04-23 1982-04-21 Verfahren zur herstellung eines aus blutbahnen gewonnenen aktiven fibrinolytischen prinzips sowie das so hergestellte enzym. ATE15071T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT48332/81A IT1170913B (it) 1981-04-23 1981-04-23 Procedimento per la produzione di un principio attivo fibrinolitico vasale prodotto enzimatico specifico angiochinasi cosi' ottenuto e sue applicazioni farmaceutiche
EP82830100A EP0064036B1 (de) 1981-04-23 1982-04-21 Verfahren zur Herstellung eines aus Blutbahnen gewonnenen aktiven fibrinolytischen Prinzips sowie das so hergestellte Enzym

Publications (1)

Publication Number Publication Date
ATE15071T1 true ATE15071T1 (de) 1985-09-15

Family

ID=11265948

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82830100T ATE15071T1 (de) 1981-04-23 1982-04-21 Verfahren zur herstellung eines aus blutbahnen gewonnenen aktiven fibrinolytischen prinzips sowie das so hergestellte enzym.

Country Status (16)

Country Link
US (2) US4471053A (de)
EP (1) EP0064036B1 (de)
JP (1) JPS57181019A (de)
AT (1) ATE15071T1 (de)
AU (1) AU548758B2 (de)
CA (1) CA1184138A (de)
DE (1) DE3265559D1 (de)
DK (1) DK180682A (de)
ES (1) ES8501797A1 (de)
IE (1) IE53107B1 (de)
IL (1) IL65448A (de)
IT (1) IT1170913B (de)
NO (1) NO821287L (de)
NZ (1) NZ200254A (de)
PT (1) PT74743B (de)
ZA (1) ZA822703B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA831399B (en) * 1982-03-05 1984-02-29 Health Lab Service Board New fibrinolytic enzymes and methods for their production and pharmaceutical compositions containing them
JPS58189122A (ja) * 1982-04-30 1983-11-04 Kaken Pharmaceut Co Ltd 高脂血症予防治療剤
JPS61112018A (ja) * 1984-11-06 1986-05-30 Mitsubishi Chem Ind Ltd 線溶増強剤
US5165938A (en) * 1984-11-29 1992-11-24 Regents Of The University Of Minnesota Wound healing agents derived from platelets
US5275812A (en) * 1985-06-07 1994-01-04 The General Hospital Corporation Method of treatment for myocardial infarction
US5032608A (en) * 1986-09-10 1991-07-16 Dudrick Stanley J Method and substrate composition for treating atherosclerosis
US5248688A (en) * 1986-09-10 1993-09-28 Dudrick Medical Research Fund I, Ltd. Method and substrate composition for treating atherosclerosis
HU209955B (en) * 1987-07-01 1994-12-28 Genentech Inc Process for producing pharmaceutical compositions containing tissue- -plasminogen-activator of poor solubility for inhibiting production and regeneration of deformities
US5215908A (en) * 1989-06-13 1993-06-01 Genencor International, Inc. Process for recovery and purification of chymosin
US5449679A (en) * 1994-07-29 1995-09-12 Leonard; Robert J. Process and products for reducing biological fluid levels of a lipid soluble waste
US7745106B2 (en) * 1997-06-24 2010-06-29 Cascade Medical Enterprises, Llc Methods and devices for separating liquid components
US20080199513A1 (en) * 1997-06-24 2008-08-21 Cascade Medical Enterprises, Llc Systems and methods for preparing autologous fibrin glue
US6979307B2 (en) * 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
WO1999066797A1 (en) 1998-06-22 1999-12-29 Worden Charles E Enriched platelet wound healant
WO2006102488A1 (en) * 2005-03-22 2006-09-28 Cascade Medical Enterprises, Llc Systems and methods of producing membranes
DE102015010436B4 (de) * 2015-08-14 2019-01-24 Airbus Defence and Space GmbH Wabenkern für dimensionsstabile Sandwichbauteile, dessen Verwendung, Sandwichplatte mit diesem Wabenkern und Verfahren zur Herstellung des Wabenkerns

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998847A (en) * 1972-10-25 1976-12-21 Schering Aktiengesellschaft 9,10-secoestrane derivatives and their production
US3998947A (en) * 1973-11-30 1976-12-21 Pierre Fabre S.A. Process for obtaining a plasminogen activator
US4245051A (en) * 1978-03-30 1981-01-13 Rockefeller University Human serum plasminogen activator
NZ191320A (en) * 1978-09-07 1982-09-14 Beecham Group Ltd In vivo fibrinolytic enzyme having active site blocked by hydrolytically removable group pharmaceutical compositions
US4374830A (en) * 1979-10-04 1983-02-22 Research Corp. Platelet aggregating material from equine arterial tissue
US4381346A (en) * 1979-11-13 1983-04-26 Huasin Syed S Isolation of plasminogen activators useful as therapeutic and diagnostic agents
US4390630A (en) * 1980-10-28 1983-06-28 The Regents Of The University Of California Hementin--a fibrinolytic agent

Also Published As

Publication number Publication date
US4471053A (en) 1984-09-11
IE53107B1 (en) 1988-06-22
IL65448A (en) 1985-07-31
CA1184138A (en) 1985-03-19
NZ200254A (en) 1985-07-12
IE820952L (en) 1982-10-23
ES511604A0 (es) 1984-12-01
DK180682A (da) 1982-10-24
ES8501797A1 (es) 1984-12-01
EP0064036B1 (de) 1985-08-21
US4532129A (en) 1985-07-30
IL65448A0 (en) 1982-07-30
PT74743B (en) 1983-11-09
DE3265559D1 (en) 1985-09-26
ZA822703B (en) 1983-03-30
PT74743A (en) 1982-05-01
EP0064036A1 (de) 1982-11-03
IT8148332A1 (it) 1982-10-23
AU8237582A (en) 1982-10-28
IT1170913B (it) 1987-06-03
AU548758B2 (en) 1986-01-02
JPS57181019A (en) 1982-11-08
IT8148332A0 (it) 1981-04-23
NO821287L (no) 1982-10-25

Similar Documents

Publication Publication Date Title
ATE15071T1 (de) Verfahren zur herstellung eines aus blutbahnen gewonnenen aktiven fibrinolytischen prinzips sowie das so hergestellte enzym.
Ohsaka Hemorrhagic, necrotizing and edema-forming effects of snake venoms
Wilhelm The mediation of increased vascular permeability in inflammation
Loskutoff Effect of thrombin on the fibrinolytic activity of cultured bovine endothelial cells.
Ratnoff et al. The activation of Christmas factor (factor IX) by activated plasma thromboplastin antecedent (activated factor XI)
Verstraeten et al. Pharmacologic induction of posterior vitreous detachment in the rabbit
Astrup et al. Thromboplastic and fibrinolytic activity of human synovial membrane and fibrous capsular tissue.
Bajwa et al. Thrombin-like and fibrinolytic enzymes in the venoms from the Gaboon viper (Bitis gabonica), eastern cottonmouth moccasin (Agkistrodon p. piscivorus) and southern copperhead (Agkistrodon c. contortrix) snakes
PT1318198E (pt) Processo para produzir um polipeptido recombinante que envolve a adicao de um inibidor de quimotripsina ao meio de cultura celular
US4334018A (en) Process and reagent for the determination of prothrombin
US4390630A (en) Hementin--a fibrinolytic agent
AU524777B2 (en) Isolation of tissue protein ppg.
UY25097A1 (es) Proceso para la produccion de heparina
HUP9901188A2 (hu) Új, meghatározott enzimkeverékek sejtkinyeréshez és sebkezeléshez
Thörig et al. Immunological characterization and possible origin of plasminogen activator in human tear fluid
AU570574B2 (en) Depolymerase enzymes and treatment of fireblight
EP0044343A4 (de) Prothrombin enthaltende therapeutische zusammensetzungen und verfahren zur herstellung enzymatisch aktiver blutgerinnungsfaktoren aus prothrombin enthaltenden blutfraktionen.
FI921847A0 (fi) Farmaceutisk komposition som har endoproteolytisk aktivitet, foerfarande foer endoproteolytisk behandling av (prekursor)proteiner samt foerfarande foer (mikro)bio- logisk framstaellning av proteiner.
SE7607908L (sv) Forfarande for forbettring av aktiviteten hos fiberinbeddade oxireduktasenzymer
Hayasaka et al. Lysosomal enzymes in subretinal fluid
NAKANO et al. Isolation and characterization of four forms of trehalase from rabbit kidney cortex
ES8602362A1 (es) Un procedimiento para la produccion de queso
Gessert et al. LXVIII The Action of Enzymes on Human Middle Ear Effusions
NL8601240A (nl) Plasminogeenactivator en trombolytisch geneesmiddel.
SE8600987D0 (sv) Forfarande for framstellning av ett protein- koncentrat ur helblod

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties